Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 15 FEB 2011 -14 FEB 2012
REPORT DATE
01-03-2012
REPORT TYPE
Annual Report
DATES COVERED
TITLE AND SUBTITLE
Mining the Immune Cell Proteome to Identify Ovarian Cancer-Specific Biomarkers
Reportable Outcomes 2Conclusions 2
Supporting Documents
3-10Appendix 1 1 Introduction: The primary goal of this project is to identify biomarkers present in immune cells that can be used for the early detection and monitoring of ovarian cancer. Immune cells are continuously exposed to self and cancer antigens. These interactions result in alterations in the transcriptome and proteome of the immune cells. We are therefore proposing that the immune cells contain disease-specific biomarkers. In the current project we proposed to carry out in-depth proteomic analysis to identify the ovarian cancer-specific biomarkers.Body: Our studies are focused on three specific aims. In the first aim we are conducting experiments to clearly define the proteome of T cells, NK cells, B cells and monocytes.In the second aim we will identify specific changes in the proteomes of immune cells in response to defined antigens derived from ovarian cancer cells. Finally, in the third specific aim experiments will be conducted to compare the proteomes of immune cells isolated from peripheral blood and peritoneal fluid of ovarian cancer patients.We have now developed streamlined protocols using NKL cells that have allowed us to conduct bottom-up proteomics to identify the proteome of immune cells. Using these streamlined protocols, we have now completed the analysis of human NK cells. This analysis has allowed us to identify approximately 2000 individual proteins in the proteome of human NK cells. This analysis is now complete and we are currently preparing a manuscript on our results that will be submitted to Journal of Proteome research. These experiments address the objectives of Specific Aim 1.Next we have also obtained data on the proteome of immune cells that are exposed IL-2. These experiments were structured to provide initial data that would show the effect on immune proteomes of factors that the immune cells are likely to encounter in the tumor micr...